Abstract:Tubulin is a potential therapeutic target for cancer. Compounds inhibit the polymerization of tubulin or promote the polymerization of tubulin to interfere with the mitotic process of cells, resulting in the interruption of cell mitosis, and then lead to apoptosis of tumor cells, playing an anti-tumor role. In this study, a series of new styrylquinolines tubulin inhibitors are designed as anti-cancer compounds by using 3D-QSAR, molecular docking and Molecular Dynamics (MD) simulation. Two reliable CoMFA (Q2=0.86, R2=0.934) and CoMSIA(Q2=0.846, R2=0.938) models of tubulin polymerization inhibitors were established. Subsequently, molecular docking was used to explore the docking mode of compounds and receptors. Based on these results, we designed eight new tubulin polymerization inhibitors and predicted their activity by using 3D-QSAR model. Molecular docking again reveals important residues for protein-compound interactions, and the results revealed tubulin polymerization inhibitors had stronger binding affinity with key residues of protein, such as Ser140, Glu183, ILE171, Thr179, Ala180, etc. Molecular Dynamics (MD) simulation further verified the results of molecular docking. The above information provided significant guidance for the design of novel tubulin polymerization inhibitors.

Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.

Synthesis, Biological Evaluation, and Molecular Modeling of Cinnamic Acyl Sulfonamide Derivatives As Novel Antitubulin Agents

Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Chalcone Oxime Derivatives As Potential Tubulin Polymerization Inhibitors

Synthesis, Biological Evaluation and 3D-QSAR Studies of Novel 5-Phenyl-1h-pyrazol Cinnamamide Derivatives As Novel Antitubulin Agents.

Discovery of Novel Tubulin Polymerization Inhibitors by Utilizing 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation

Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site.

Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor

Design, Synthesis and Biological Evaluation of Novel 4-(4-Methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as Tubulin Polymerization Inhibitors

Synthesis, Molecular Docking and Biological Evaluation of 1-Phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Novel Potential Tubulin Assembling Inhibitors

Design, Synthesis and Biological Evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine Derivatives As A New Class of Tubulin Polymerization Inhibitors

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1-Benzene Acyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Potential Tubulin Polymerization Inhibitors

Design, synthesis, biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors.

Design, Synthesis and Biological Evaluation of Novel Diarylpyridine Derivatives As Tubulin Polymerisation Inhibitors

Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.

Design, Synthesis and Biological Evaluation of Novel Dihydroquinolin-4(1H)-one Derivatives As Novel Tubulin Polymerization Inhibitors

Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors

Synthesis, Biological Evaluation and Molecular Modeling of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Antitubulin Agents.

Design, Synthesis, Biological Evaluation And Molecular Modeling Of 1,3,4-Oxadiazoline Analogs Of Combretastatin-A4 As Novel Antitubulin Agents

Synthesis and Bioevaluation of N,4-diaryl-1,3-thiazole-2-amines As Tubulin Inhibitors with Potent Antiproliferative Activity.

Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors